RecruitingNot Applicable

Influence of Vertical Implant Position on Marginal Bone Loss in Cases With Thin Phenotype

Egypt30 participantsStarted 2025-01-16

Plain-language summary

The goal of this clinical trial is to learn if vertical position of the dental implant will affect the bone around the implant in place of a missing tooth that happens to be bounded by two natural teeth. It will also measure esthetics and patient satisfaction. The main questions it aims to answer are: Does vertical implant position below the crest of the bone lead to less marginal bone loss? Will it affect implant survival as well as quality of soft tissue, esthetics and patient satisfaction? Participants will: Have an implant placed at the bone level or 2 mm below the bone level Visit the clinic once every 3 months for checkups, radiographs, and readings

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with single missing upper anterior or premolar teeth * Patients with minimum buccolingual width of 6 mm and mesiodistal width of 6 mm * Patients with thin soft tissue phenotype * Patients with healthy systemic conditions. * Patients older than 18 years. * Good oral hygiene. * Cooperative patients who accept a one-year follow-up period. * Patients who consent to being part of the study (sign an informed consent form). * Adequate inter-arch space for implant placement. * Favorable occlusion (no traumatic occlusion). * Absence of allergy to the prescribed medications. Exclusion Criteria: * Patients with inadequate bone volume and/ or quality * Patients with local root remnants * Patients with inadequate wound healing * Patients with signs of acute infection related to the area of interest. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits (Lobbezoo et al., 2006). * Heavy smokers (more than 10 cigarettes per day) (Lambert, Morris and Ochi, 2000). * Metabolic diseases such as diabetes or hyperthyroidism as well as systemic medications such as chemotherapy or bisphosphonates * Pregnant or nursing women. * Uncooperative patients.

What they're measuring

Marginal bone loss (crestal bone loss)

Timeframe: Assessment at baseline, 3 months post-operative, 6 months post-operative, 9 months post-operative and 12 months post-operative

Trial details

NCT IDNCT07483086

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02